Matches in SemOpenAlex for { <https://semopenalex.org/work/W164087343> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W164087343 endingPage "46" @default.
- W164087343 startingPage "1033" @default.
- W164087343 abstract "Physicians have little evidentiary guidance for pharmacologic agent selection for atrial fibrillation (AF).To assess antiarrhythmic agent efficacy for AF conversion and subsequent maintenance of sinus rhythm (MSR).We searched the clinical trial database of the Cochrane Collaboration and MEDLINE encompassing literature from 1948 to May 1998.We selected 36 (28%) articles eligible as randomized trials of nonpostoperative AF conversion or MSR in adults.Study quality; rates of conversion, MSR, and adverse events were extracted.Compared with control treatment (placebo, verapamil, diltiazem, or digoxin), the odds ratio (OR) for conversion was greatest for ibutilide/dofetilide (OR=29.1; 95% confidence interval [CI], 9.8-86.1) and flecainide (OR=24.7; 95% CI, 9.0-68.3). Less strong but conclusive evidence existed for propafenone (OR=4.6; 95% CI, 2.6-8.2). Quinidine (OR=2.9; 95% CI, 1.2-7.0) had moderate evidence of efficacy for conversion. Disopyramide (OR=7.0; 95% CI, 0.3-153.0) and amiodarone (OR=5.7; 95% CI, 1.0-33.4) had suggestive evidence of efficacy. Sotalol (OR=0.4; 95% CI, 0.0-3.0) had suggestive evidence of negative efficacy. For MSR, strong evidence of efficacy existed for quinidine (OR=4.1; 95% CI, 2.5-6.7), disopyramide (OR=3.4; CI, 1.6-7.1), flecainide (OR=3.1; 95% CI, 1.5-6.2), propafenone (OR=3.7; 95% CI, 2.4-5.7), and sotalol (OR=7.1; 95% CI, 3.8-13.4). The only amiodarone data, from comparison with disopyramide, provided moderate evidence of efficacy for MSR. No trial evaluated procainamide. Direct agent comparisons and adverse event data were limited.Although multiple antiarrhythmic agents had strong evidence of efficacy compared with control treatment for MSR, ibutilide/dofetilide and flecainide had particularly strong evidence of efficacy compared with control treatment for AF conversion. There is sparse and inconclusive evidence on direct agent comparisons and adverse event rates. Obtaining information regarding these relative efficacies should be a research priority." @default.
- W164087343 created "2016-06-24" @default.
- W164087343 creator A5005231494 @default.
- W164087343 creator A5012707345 @default.
- W164087343 creator A5014680925 @default.
- W164087343 creator A5033522843 @default.
- W164087343 creator A5046077510 @default.
- W164087343 creator A5049055973 @default.
- W164087343 creator A5064913557 @default.
- W164087343 creator A5072207889 @default.
- W164087343 date "2000-11-01" @default.
- W164087343 modified "2023-10-18" @default.
- W164087343 title "Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials." @default.
- W164087343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11093570" @default.
- W164087343 hasPublicationYear "2000" @default.
- W164087343 type Work @default.
- W164087343 sameAs 164087343 @default.
- W164087343 citedByCount "38" @default.
- W164087343 countsByYear W1640873432012 @default.
- W164087343 countsByYear W1640873432013 @default.
- W164087343 countsByYear W1640873432017 @default.
- W164087343 countsByYear W1640873432019 @default.
- W164087343 crossrefType "journal-article" @default.
- W164087343 hasAuthorship W164087343A5005231494 @default.
- W164087343 hasAuthorship W164087343A5012707345 @default.
- W164087343 hasAuthorship W164087343A5014680925 @default.
- W164087343 hasAuthorship W164087343A5033522843 @default.
- W164087343 hasAuthorship W164087343A5046077510 @default.
- W164087343 hasAuthorship W164087343A5049055973 @default.
- W164087343 hasAuthorship W164087343A5064913557 @default.
- W164087343 hasAuthorship W164087343A5072207889 @default.
- W164087343 hasConcept C126322002 @default.
- W164087343 hasConcept C156957248 @default.
- W164087343 hasConcept C164705383 @default.
- W164087343 hasConcept C168563851 @default.
- W164087343 hasConcept C2775914520 @default.
- W164087343 hasConcept C2776639339 @default.
- W164087343 hasConcept C2777707475 @default.
- W164087343 hasConcept C2777796741 @default.
- W164087343 hasConcept C2778094803 @default.
- W164087343 hasConcept C2778131192 @default.
- W164087343 hasConcept C2778198053 @default.
- W164087343 hasConcept C2779161974 @default.
- W164087343 hasConcept C2779215400 @default.
- W164087343 hasConcept C2779837460 @default.
- W164087343 hasConcept C2780074459 @default.
- W164087343 hasConcept C2780339425 @default.
- W164087343 hasConcept C2781472538 @default.
- W164087343 hasConcept C44249647 @default.
- W164087343 hasConcept C71924100 @default.
- W164087343 hasConceptScore W164087343C126322002 @default.
- W164087343 hasConceptScore W164087343C156957248 @default.
- W164087343 hasConceptScore W164087343C164705383 @default.
- W164087343 hasConceptScore W164087343C168563851 @default.
- W164087343 hasConceptScore W164087343C2775914520 @default.
- W164087343 hasConceptScore W164087343C2776639339 @default.
- W164087343 hasConceptScore W164087343C2777707475 @default.
- W164087343 hasConceptScore W164087343C2777796741 @default.
- W164087343 hasConceptScore W164087343C2778094803 @default.
- W164087343 hasConceptScore W164087343C2778131192 @default.
- W164087343 hasConceptScore W164087343C2778198053 @default.
- W164087343 hasConceptScore W164087343C2779161974 @default.
- W164087343 hasConceptScore W164087343C2779215400 @default.
- W164087343 hasConceptScore W164087343C2779837460 @default.
- W164087343 hasConceptScore W164087343C2780074459 @default.
- W164087343 hasConceptScore W164087343C2780339425 @default.
- W164087343 hasConceptScore W164087343C2781472538 @default.
- W164087343 hasConceptScore W164087343C44249647 @default.
- W164087343 hasConceptScore W164087343C71924100 @default.
- W164087343 hasIssue "11" @default.
- W164087343 hasLocation W1640873431 @default.
- W164087343 hasOpenAccess W164087343 @default.
- W164087343 hasPrimaryLocation W1640873431 @default.
- W164087343 hasRelatedWork W164087343 @default.
- W164087343 hasRelatedWork W1966469023 @default.
- W164087343 hasRelatedWork W1969636914 @default.
- W164087343 hasRelatedWork W1995602139 @default.
- W164087343 hasRelatedWork W2016293566 @default.
- W164087343 hasRelatedWork W2043730547 @default.
- W164087343 hasRelatedWork W2113883980 @default.
- W164087343 hasRelatedWork W2139439166 @default.
- W164087343 hasRelatedWork W2442855647 @default.
- W164087343 hasRelatedWork W4232012798 @default.
- W164087343 hasVolume "49" @default.
- W164087343 isParatext "false" @default.
- W164087343 isRetracted "false" @default.
- W164087343 magId "164087343" @default.
- W164087343 workType "article" @default.